Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis

por Chapin, William J., Hwang, Wei‐Ting, Karasic, Thomas B., McCarthy, Anne Marie, Kaplan, David E.
Publicado 2022

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer

por Dreyfuss, Alexandra D., Barsky, Andrew R., Wileyto, E. Paul, Eads, Jennifer R., Kucharczuk, John C., Williams, Noel N., Karasic, Thomas B., Metz, James M., Ben‐Josef, Edgar, Plastaras, John P., Wojcieszynski, Andrzej P.
Publicado 2021

Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer

por Karasic, Thomas B, Brown, Timothy J, Schneider, Charles, Teitelbaum, Ursina R, Reiss, Kim A, Mitchell, Tara C, Massa, Ryan C, O’Hara, Mark H, DiCicco, Lisa, Garcia-Marcano, Luis, Amaravadi, Ravi K, O’Dwyer, Peter J
Publicado 2022

DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models

por Romanello Joaquim, Miguel, Furth, Emma E., Fan, Yong, Song, Hee Kwon, Pickup, Stephen, Cao, Jianbo, Choi, Hoon, Gupta, Mamta, Cao, Quy, Shinohara, Russell, McMenamin, Deirdre, Clendenin, Cynthia, Karasic, Thomas B., Duda, Jeffrey, Gee, James C., O’Dwyer, Peter J., Rosen, Mark A., Zhou, Rong
Publicado 2022